In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide.
Tenofovir gel has entered into clinical trials for use as a topical microbicide to prevent HIV-1 infection but has no published data regarding pre-clinical testing using in vitro and ex vivo models. To validate our findings with on-going clinical trial results, we evaluated topical tenofovir gel for...
Main Authors: | Lisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, Marilyn Cost, Yunda Huang, Fang Gai, Nicole Billitto, J D Lynam, Kara Pryke, Phillip Graebing, Nicole Hopkins, James F Rooney, David Friend, Charlene S Dezzutti |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-02-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2824823?pdf=render |
Similar Items
-
Is wetter better? An evaluation of over-the-counter personal lubricants for safety and anti-HIV-1 activity.
by: Charlene S Dezzutti, et al.
Published: (2012-01-01) -
Can a topical microbicide prevent rectal HIV transmission?
by: Florian Hladik, et al.
Published: (2008-08-01) -
Development of HIV-1 rectal-specific microbicides and colonic tissue evaluation.
by: Charlene S Dezzutti, et al.
Published: (2014-01-01) -
Oleate lipase activity in <it>Gardnerella vaginalis </it>and reconsideration of existing biotype schemes
by: Moncla Bernard J, et al.
Published: (2009-04-01) -
A multi-compartment, single and multiple dose pharmacokinetic study of the vaginal candidate microbicide 1% tenofovir gel.
by: Jill L Schwartz, et al.
Published: (2011-01-01)